Used for diagnosing gastroesophageal reflux, the devices may not attach or detach correctly, potentially causing serious ...

Right now one of the best healthcare stocks to look at is medical device giant Medtronic ( MDT 0.39%), which is offering a ...

With EU CE mark clearance for LigaSure RAS, Medtronic expands the Hugo system’s capabilities in gynaecologic and urologic ...

Medtronic (NYSE: MDT) today announced the first patient enrolled in the PELE trial of its Onyx liquid embolic system (LES).

Medtronic's Jason Fontana offers an update on next-generation Symplicity Spyral devices, procedures and a new feature they're ...

Medtronic announced today that it received CE mark for its LigaSure vessel sealing technology for use with its Hugo system.

Medtronic said its market-leading LigaSure technology can now be used with its Hugo soft tissue robotic surgery system in Europe.

CMS proposed Medicare coverage for Medtronic's renal denervation therapy for high blood pressure, signaling a key step toward ...

However, in the postreform healthcare world where there are higher hurdles for securing reimbursement for next-generation technology, Medtronic has had to move in the direction of introducing ...

Medtronic reported that it has begun testing an expansion of its renal denervation approach for dropping stubbornly high ...

Analysts fell to the sidelines weighing in on Medtronic (MDT – Research Report) and Exelixis (EXEL – Research Report) with neutral ratings, indicating that the experts are nei ...

Medtronic PLC closed 7.97% below its 52-week high of $96.25, which the company achieved on March 10th.